{"DataElement":{"publicId":"8037896","version":"1","preferredName":"Volume Residual Disease Present Status","preferredDefinition":"Information regarding the volume of residual tumor.","longName":"RESID_DISEASE_VOL_STAT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"8032599","version":"1","preferredName":"Volume Residual Disease Present","preferredDefinition":"The amount of three dimensional space occupied by an object or the capacity of a space or container.:Tumor cells that remain in the body following cancer treatment._Being or existing in a specified place or at the specified time.","longName":"2239882v1.0:2228366v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"11410247","version":"1","preferredName":"Volume","preferredDefinition":"The amount of three dimensional space occupied by an object or the capacity of a space or container.","longName":"C25335","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Volume","conceptCode":"C25335","definition":"The amount of three dimensional space occupied by an object or the capacity of a space or container.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EAAF48FF-5993-7CE8-E053-731AD00A6766","latestVersionIndicator":"Yes","beginDate":"2022-10-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-10-10","modifiedBy":"KUMMEROA","dateModified":"2022-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"11410248","version":"1","preferredName":"Residual Disease Present","preferredDefinition":"Tumor cells that remain in the body following cancer treatment._Being or existing in a specified place or at the specified time.","longName":"C4809:C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EAAF48FF-5994-7CE8-E053-731AD00A6766","latestVersionIndicator":"Yes","beginDate":"2022-10-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-10-10","modifiedBy":"KUMMEROA","dateModified":"2022-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D79DF4F0-D104-74A2-E053-4EBD850AE6F8","latestVersionIndicator":"Yes","beginDate":"2022-02-09","endDate":null,"createdBy":"TITARENI","dateCreated":"2022-02-09","modifiedBy":"KUMMEROA","dateModified":"2022-10-10","changeDescription":"2/9/22 created for COG to use instead of DEC 5804072_TI","administrativeNotes":"2022.10.10 Reviewed and released. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5807084","version":"2","preferredName":"Residual Disease Volume Status","preferredDefinition":"A condition or state at a particular time.","longName":"5807084v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"< 5 ml remaining","valueDescription":"Less Than 5 Millimeter Remaining","ValueMeaning":{"publicId":"5839941","version":"1","preferredName":"Less Than 5 Millimeter Remaining","longName":"5839941","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.: A number with no fractional part, including the negative and positive numbers as well as zero.::5: A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch.: Enduring or persisting; residual, left over or behind.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than","conceptCode":"C61585","definition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Millimeter","conceptCode":"C28251","definition":"A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Remaining","conceptCode":"C25649","definition":"Enduring or persisting; residual, left over or behind.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50C633AF-7081-4687-E053-F662850ABA1F","latestVersionIndicator":"Yes","beginDate":"2017-05-30","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D7AEB1DA-B2D2-3BD2-E053-4EBD850A0AFF","beginDate":"2017-05-30","endDate":null,"createdBy":"TITARENI","dateCreated":"2022-02-10","modifiedBy":"ONEDATA","dateModified":"2022-02-10","deletedIndicator":"No"},{"value":">/= 5 ml remaining","valueDescription":"Greater Than or Equal To 5 Millimeter Remaining","ValueMeaning":{"publicId":"5839942","version":"1","preferredName":"Greater Than or Equal To 5 Millimeter Remaining","longName":"5839942","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.: A number with no fractional part, including the negative and positive numbers as well as zero.::5: A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch.: Enduring or persisting; residual, left over or behind.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Millimeter","conceptCode":"C28251","definition":"A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Remaining","conceptCode":"C25649","definition":"Enduring or persisting; residual, left over or behind.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50C633AF-70A9-4687-E053-F662850ABA1F","latestVersionIndicator":"Yes","beginDate":"2017-05-30","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D7AEB1DA-B2DC-3BD2-E053-4EBD850A0AFF","beginDate":"2017-05-04","endDate":null,"createdBy":"TITARENI","dateCreated":"2022-02-10","modifiedBy":"ONEDATA","dateModified":"2022-02-10","deletedIndicator":"No"},{"value":"Biospy only performed","valueDescription":"Biopsy Performed","ValueMeaning":{"publicId":"5807085","version":"1","preferredName":"Biopsy Performed","longName":"5807085","preferredDefinition":"The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.: Executed and carried through to completion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biopsy","conceptCode":"C15189","definition":"The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EB738DA-48C8-233D-E053-F662850A7E3E","latestVersionIndicator":"Yes","beginDate":"2017-05-04","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D7AEB1DA-B2E6-3BD2-E053-4EBD850A0AFF","beginDate":"2017-05-04","endDate":null,"createdBy":"TITARENI","dateCreated":"2022-02-10","modifiedBy":"ONEDATA","dateModified":"2022-02-10","deletedIndicator":"No"},{"value":"No visible residual tumor seen by surgeon","valueDescription":"Negation Visible Neoplasm","ValueMeaning":{"publicId":"5807088","version":"1","preferredName":"Negation Visible Neoplasm","longName":"5807088","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Perceptible especially by the eye; open to easy view.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Visible","conceptCode":"C48173","definition":"Perceptible especially by the eye; open to easy view.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EB738DA-493F-233D-E053-F662850A7E3E","latestVersionIndicator":"Yes","beginDate":"2017-05-04","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D7AEB1DA-B2F0-3BD2-E053-4EBD850A0AFF","beginDate":"2017-05-04","endDate":null,"createdBy":"TITARENI","dateCreated":"2022-02-10","modifiedBy":"ONEDATA","dateModified":"2022-02-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2842596","version":"1","preferredName":"Outcome of Therapy","preferredDefinition":"The result of therapy for a given disease or condition in a patient or group of patients.","longName":"C18919 ","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63D982FA-DFBF-58C7-E040-BB89AD433E84","latestVersionIndicator":"Yes","beginDate":"2009-02-26","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-02-26","modifiedBy":"CURTIST","dateModified":"2009-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7AEB1DA-B2BD-3BD2-E053-4EBD850A0AFF","latestVersionIndicator":"Yes","beginDate":"2017-05-04","endDate":null,"createdBy":"TITARENI","dateCreated":"2022-02-10","modifiedBy":"KUMMEROA","dateModified":"2022-10-10","changeDescription":"2/10/22 versioned due to the Long Name change and addition of Max Length and Registr. Status_TI","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Volume of residual tumor:","type":"Preferred Question Text","description":"Volume of residual tumor:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7ACE3EF-B9B2-17E9-E053-4EBD850ABC3E","latestVersionIndicator":"Yes","beginDate":"2022-02-10","endDate":null,"createdBy":"TITARENI","dateCreated":"2022-02-10","modifiedBy":"KUMMEROA","dateModified":"2022-10-10","changeDescription":"2/10/22 created for COG to use instead of CDE 5807223_TI","administrativeNotes":"2022.10.10 Reviewed and released. ak","unresolvedIssues":null,"deletedIndicator":"No"}}